These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2211666)

  • 41. Cysteine residues in the active site of Corynebacterium sarcosine oxidase.
    Suzuki H; Kawamura-Konishi Y
    J Biochem; 1991 Jun; 109(6):909-17. PubMed ID: 1939012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cysteine-scanning mutagenesis around transmembrane segments 1 and 11 and their flanking loop regions of Tn10-encoded metal-Tetracycline/H+ antiporter.
    Kimura-Someya T; Iwaki S; Konishi S; Tamura N; Kubo Y; Yamaguchi A
    J Biol Chem; 2000 Jun; 275(25):18692-7. PubMed ID: 10747900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and localization of a cysteinyl residue critical for the trypsin-like catalytic activity of the proteasome.
    Dick LR; Moomaw CR; Pramanik BC; DeMartino GN; Slaughter CA
    Biochemistry; 1992 Aug; 31(32):7347-55. PubMed ID: 1510924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the essential cysteine residue in the active site of bovine pyruvate dehydrogenase.
    Ali MS; Roche TE; Patel MS
    J Biol Chem; 1993 Oct; 268(30):22353-6. PubMed ID: 8226745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitochondrial membrane protein thiol reactivity with N-ethylmaleimide or mersalyl is modified by Ca2+: correlation with mitochondrial permeability transition.
    Kowaltowski AJ; Vercesi AE; Castilho RF
    Biochim Biophys Acta; 1997 Feb; 1318(3):395-402. PubMed ID: 9048976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites.
    Stenina OI; Ustinov V; Krukovets I; Marinic T; Topol EJ; Plow EF
    FASEB J; 2005 Nov; 19(13):1893-5. PubMed ID: 16148025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineered cysteine mutants of myosin light chain 2. Fluorescent analogues for structural studies.
    Saraswat LD; Lowey S
    J Biol Chem; 1991 Oct; 266(29):19777-85. PubMed ID: 1918082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding.
    Asch AS; Silbiger S; Heimer E; Nachman RL
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1208-17. PubMed ID: 1371676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structure of human platelet thrombospondin.
    Lawler J; Derick LH; Connolly JE; Chen JH; Chao FC
    J Biol Chem; 1985 Mar; 260(6):3762-72. PubMed ID: 2579080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
    Leung LL; Li WX; McGregor JL; Albrecht G; Howard RJ
    J Biol Chem; 1992 Sep; 267(25):18244-50. PubMed ID: 1381367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Context-dependent monoclonal antibodies against protein carbamidomethyl-cysteine.
    Cartee NMP; Lee SJ; Keep SG; Wang MM
    PLoS One; 2020; 15(11):e0242376. PubMed ID: 33232360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disulfide formation within the regulatory light chain of skeletal muscle myosin.
    Huber PJ; Brunner UT; Schaub MC
    Biochemistry; 1989 Nov; 28(23):9116-23. PubMed ID: 2605244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombospondin binding to specific sequences within the A alpha- and B beta-chains of fibrinogen.
    Bacon-Baguley T; Ogilvie ML; Gartner TK; Walz DA
    J Biol Chem; 1990 Feb; 265(4):2317-23. PubMed ID: 2298752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain.
    Tuszynski GP; Rothman VL; Papale M; Hamilton BK; Eyal J
    J Cell Biol; 1993 Jan; 120(2):513-21. PubMed ID: 8421063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation.
    Kurtenbach E; Curtis CA; Pedder EK; Aitken A; Harris AC; Hulme EC
    J Biol Chem; 1990 Aug; 265(23):13702-8. PubMed ID: 2380182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thiol metabolomics of endothelial cells using capillary liquid chromatography mass spectrometry with isotope coded affinity tags.
    Yuan W; Edwards JL
    J Chromatogr A; 2011 May; 1218(18):2561-8. PubMed ID: 21420094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterizing closely spaced, complex disulfide bond patterns in peptides and proteins by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Yen TY; Yan H; Macher BA
    J Mass Spectrom; 2002 Jan; 37(1):15-30. PubMed ID: 11813307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-Ethylmaleimide induces disaggregation of platelets preaggregated by ADP and thrombin and decreases cytoplasmic calcium level.
    Samal AB; Loiko EN
    Biochemistry (Mosc); 2000 Feb; 65(2):230-6. PubMed ID: 10713553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A serum response element and a binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene.
    Framson P; Bornstein P
    J Biol Chem; 1993 Mar; 268(7):4989-96. PubMed ID: 8444876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assay of thiols and disulfides based on the reversibility of N-ethylmaleimide alkylation of thiols combined with electrolysis.
    Nishiyama J; Kuninori T
    Anal Biochem; 1992 Feb; 200(2):230-4. PubMed ID: 1632486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.